Company · CIK 0001787740 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Valion Bio, Inc. · VBIO
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 18, 2026 FMForm 4 → | Sep 24, 4:45 pm EDT | Lisa G WolfCOO & CFO | 6 | $2.12 | $4 | 27 | — | late |
| Jun 18, 2026 MForm 4 → | Jun 18, 4:30 pm EDT | Lisa G WolfChief Financial Officer | 92 | — | — | 618 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 22, 2026 AForm 4 → | Sep 24, 4:46 pm EDT | Dean ZikriaInterim CEO, Director | 50,000 | — | — | 50,000 | — | |
| Sep 18, 2026 MForm 4 → | Sep 24, 4:45 pm EDT | Lisa G WolfCOO & CFO | 4 | — | — | 19 | — | late |
| Jun 18, 2026 MForm 4 → | Jun 18, 4:30 pm EDT | Lisa G WolfChief Financial Officer | 92 | — | — | 551 | — |